GOSS
Gossamer Bio Inc
NASDAQ: GOSS · HEALTHCARE · BIOTECHNOLOGY
$0.37
+5.21% today
Updated 2026-04-30
Market cap
$81.79M
P/E ratio
—
P/S ratio
1.69x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$0 – $4
Volume
18.7M
Gossamer Bio Inc (GOSS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $20000.00 | $-5.75M | $-51.04M | $-144.83M | $-176.36M | $-188.89M | $-187.03M | $-159.16M | $-3.47M | $-171.27M |
| Capital expenditures | $3.49M | $3.49M | $21.21M | $6.57M | $24.88M | $1.62M | $475000.00 | $0.00 | $0.00 | $79000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $32000.00 | $30.95M | $20.82M | $38.75M | $32.01M | $42.55M | $28.52M | $20.62M | $10.55M |
| Free cash flow | $-3.47M | $-9.23M | $-72.25M | $-151.40M | $-201.24M | $-190.51M | $-187.51M | $-159.16M | $-3.47M | $-171.34M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $29.60M | $351.52M | $-302.99M | $-70.98M | — | — | — |